ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Kanaph Therapeutics Closes 21M USD Series B Funding
October 15, 2020Kanaph Therapeutics, a leading biotech in oncology, auto-immune, and eye diseases with large molecules and small molecules, recently completed their Series B funding of 21M USD in South Korea. -
Samsung Biologics signs strategic partnership with Kanaph Therapeutics to develop treatment for retinal diseases
September 27, 2020Samsung Biologics and Kanaph Therapeutics have entered into a strategic partnership to develop KNP-301, a bi-specific Fc fusion protein intended to treat retinal diseases.
Pharma Sources Insight January 2025
